Busca avançada
Ano de início
Entree
(Referência obtida automaticamente do Web of Science, por meio da informação sobre o financiamento pela FAPESP e o número do processo correspondente, incluída na publicação pelos autores.)

Melatonin decreases breast cancer metastasis by modulating Rho-associated kinase protein-1 expression

Texto completo
Autor(es):
Mostrar menos -
Borin, Thaiz Ferraz [1] ; Arbab, Ali Syed [2] ; Gelaleti, Gabriela Bottaro [3, 1] ; Ferreira, Livia Carvalho [3, 1] ; Moschetta, Marina Gobbe [1] ; Jardim-Perassi, Bruna Victorasso [1] ; Iskander, A. S. M. [2] ; Varma, Nadimpalli Ravi S. [4] ; Shankar, Adarsh [2] ; Coimbra, Verena Benedick [1] ; Fabri, Vanessa Alves [1] ; de Oliveira, Juliana Garcia [5] ; Pires de Campos Zuccari, Debora Aparecida [3, 1]
Número total de Autores: 13
Afiliação do(s) autor(es):
[1] Fac Med Sao Jose Rio Preto FAMERP, Dept Mol Biol, LIMC, BR-15090000 Sao Jose Do Rio Preto, SP - Brazil
[2] Georgia Regents Univ, Ctr Canc, Tumor Angiogenesis Lab, Augusta, GA - USA
[3] Univ Estadual Paulista Julio de Mesquita Filho IB, Sao Jose Do Rio Preto, SP - Brazil
[4] Henry Ford Hosp, Dept Radiol, Cellular & Mol Imaging Lab, Detroit, MI 48202 - USA
[5] Univ Sagrado Coracao, Bauru, SP - Brazil
Número total de Afiliações: 5
Tipo de documento: Artigo Científico
Fonte: Journal of Pineal Research; v. 60, n. 1, p. 3-15, JAN 2016.
Citações Web of Science: 51
Resumo

The occurrence of metastasis, an important breast cancer prognostic factor, depends on cell migration/invasion mechanisms, which can be controlled by regulatory and effector molecules such as Rho-associated kinase protein (ROCK-1). Increased expression of this protein promotes tumor growth and metastasis, which can be restricted by ROCK-1 inhibitors. Melatonin has shown oncostatic, antimetastatic, and anti-angiogenic effects and can modulate ROCK-1 expression. Metastatic and nonmetastatic breast cancer cell lines were treated with melatonin as well as with specific ROCK-1 inhibitor (Y27632). Cell viability, cell migration/invasion, and ROCK-1 gene expression and protein expression were determined in vitro. In vivo lung metastasis study was performed using female athymic nude mice treated with either melatonin or Y27832 for 2 and 5 wk. The metastases were evaluated by X-ray computed tomography and single photon emission computed tomography (SPECT) and by immunohistochemistry for ROCK-1 and cytokeratin proteins. Melatonin and Y27632 treatments reduced cell viability and invasion/migration of both cell lines and decreased ROCK-1 gene expression in metastatic cells and protein expression in nonmetastatic cell line. The numbers of `hot' spots (lung metastasis) identified by SPECT images were significantly lower in treated groups. ROCK-1 protein expression also was decreased in metastatic foci of treated groups. Melatonin has shown to be effective in controlling metastatic breast cancer in vitro and in vivo, not only via inhibition of the proliferation of tumor cells but also through direct antagonism of metastatic mechanism of cells rendered by ROCK-1 inhibition. When Y27632 was used, the effects were similar to those found with melatonin treatment. (AU)

Processo FAPESP: 11/13154-0 - Avaliação in vitro e in vivo da metástase mediada pelo ROCK e miR-17 no câncer de mama em resposta aos tratamentos com melatonina e curcumina
Beneficiário:Debora Aparecida Pires de Campos Zuccari
Linha de fomento: Auxílio à Pesquisa - Regular
Processo FAPESP: 11/20850-3 - Avaliação in vitro e in vivo da metástase mediada pelo ROCK-1 e miR-17 no câncer de mama em resposta aos tratamentos com melatonina e curcumina
Beneficiário:Thaiz Ferraz Borin
Linha de fomento: Bolsas no Brasil - Pós-Doutorado
Processo FAPESP: 11/18986-4 - Análise imunocitoquímica da expressão proteica da quinase rock no câncer de mama em resposta ao tratamento com melatonina
Beneficiário:Vanessa Alves Fabri
Linha de fomento: Bolsas no Brasil - Iniciação Científica
Processo FAPESP: 12/12114-8 - Avaliação da metástase mediada pelo ROCK-1 e miR-17 no câncer de mama em resposta ao tratamento com melatonina e curcumina
Beneficiário:Thaiz Ferraz Borin
Linha de fomento: Bolsas no Exterior - Estágio de Pesquisa - Pós-Doutorado
Processo FAPESP: 11/18987-0 - Avaliação in vitro da migração e invasão celular no câncer de mama em resposta ao tratamento com melatonina
Beneficiário:Verena Benedick Coimbra
Linha de fomento: Bolsas no Brasil - Iniciação Científica